UC Berkeley’s cell therapy developer has filed for an initial public offering.

Ant Group is set to score an exit when the financial technology platform operator lists in Korea next month in an IPO sized at up to $1.5bn.

The BMW, Dell and Robert Bosch-backed manufacturing services platform has added just over $44m to its initial public offering, its shares having risen 58%.

AbbVie, Novartis, Corteva and Heritage Medical Systems will have an opportunity to exit the cell therapy developer through an initial public offering.

ClalTech is set to exit the cloud infrastructure management software provider in an acquisition by HPE, which will integrate Zerto with its storage division.

Accenture, Chevron, ConocoPhillips, General Electric, Intel, Shell and Saudi Aramco have all exited the operations management software provider in a purchase by SparkCognition.

GV helped geometric search technology developer Physna raise $56m while multiple corporates took part in a round nearly doubling study app developer Mathpresso's total funding to $105m.

Alphabet and Roc Nation are in line for exits as the online trading platform operator prepares for a flotation potentially valuing it at $40bn.

NTT Docomo, Capital One and Phoenix Insurance could exit the fraud detection software provider, which has announced its intention to float on the New York Stock Exchange.

GlaxoSmithKline, Johnson & Johnson and DaVita HealthCare Partners had invested in the medical device provider before it floated above its range.